The Indian pharmaceutical industry includes a network of 3,000 drug companies and 10,500 manufacturing units. It is projected to reach a value of US$ 130 billion by 2030
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
The collaboration between CORONA and Ferring will cater to patients across India
The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments
The planned bioprocessing facility would support commercial manufacturing for biotech and pharmaceutical customers across Asia-Pacific.
The partnership will capitalize on the combined capabilities of the two organizations
The news on a shift in its focus comes after the refinement of Bayer’s early innovation framework
Enabling clinical effectiveness via a fully interoperable and integrated digital pathology solution
Fully equipped labs with 75-member team set-up and made operational in <100 days
With a focus on optimizing patient experience with next-generation oral dosage forms, the US facility complements the cutting-edge research activities of Roquette’s existing pharma innovation centers in France and Singapore
Subscribe To Our Newsletter & Stay Updated
